B. Martino

2.1k total citations
17 papers, 733 citations indexed

About

B. Martino is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, B. Martino has authored 17 papers receiving a total of 733 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 6 papers in Genetics and 5 papers in Rheumatology. Recurrent topics in B. Martino's work include Chronic Myeloid Leukemia Treatments (7 papers), Acute Myeloid Leukemia Research (5 papers) and Eosinophilic Disorders and Syndromes (5 papers). B. Martino is often cited by papers focused on Chronic Myeloid Leukemia Treatments (7 papers), Acute Myeloid Leukemia Research (5 papers) and Eosinophilic Disorders and Syndromes (5 papers). B. Martino collaborates with scholars based in Italy, United States and Spain. B. Martino's co-authors include Giuseppe Saglio, F Mandelli, Susanne Saußele, Norbert Gattermann, Valentín García‐Gutiérrez, Andreas Hochhaus, Jerald P. Radich, Nancy Krunic, Andrzej Hellmann and David M. Ross and has published in prestigious journals such as Clinical Infectious Diseases, Annals of Oncology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

B. Martino

16 papers receiving 720 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Martino Italy 12 482 442 218 199 136 17 733
Maria Aparecida Zanichelli Brazil 12 226 0.5× 179 0.4× 67 0.3× 194 1.0× 105 0.8× 28 469
Hassan B. Alkhateeb United States 14 502 1.0× 222 0.5× 40 0.2× 116 0.6× 190 1.4× 148 743
Kayleigh Marx United States 10 368 0.8× 117 0.3× 24 0.1× 122 0.6× 195 1.4× 21 620
M Vigier France 9 150 0.3× 120 0.3× 57 0.3× 147 0.7× 33 0.2× 12 326
Federica Galaverna Italy 15 581 1.2× 115 0.3× 20 0.1× 333 1.7× 57 0.4× 48 867
Kristen Pettit United States 12 320 0.7× 187 0.4× 56 0.3× 71 0.4× 221 1.6× 66 550
Miquel Granell Spain 12 260 0.5× 174 0.4× 58 0.3× 90 0.5× 173 1.3× 15 515
P. Y. Le Prise France 10 285 0.6× 112 0.3× 32 0.1× 156 0.8× 137 1.0× 19 495
Anna B. Halpern United States 14 674 1.4× 216 0.5× 45 0.2× 216 1.1× 220 1.6× 74 907
Carol Bivins United States 9 244 0.5× 165 0.4× 39 0.2× 102 0.5× 158 1.2× 13 432

Countries citing papers authored by B. Martino

Since Specialization
Citations

This map shows the geographic impact of B. Martino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Martino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Martino more than expected).

Fields of papers citing papers by B. Martino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Martino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Martino. The network helps show where B. Martino may publish in the future.

Co-authorship network of co-authors of B. Martino

This figure shows the co-authorship network connecting the top 25 collaborators of B. Martino. A scholar is included among the top collaborators of B. Martino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Martino. B. Martino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
3.
Hochhaus, Andreas, Tamás Masszi, Francis J. Giles, et al.. (2017). Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study. Leukemia. 31(7). 1525–1531. 203 indexed citations
4.
Al‐Ali, Haifa Kathrin, Martin Grießhammer, Philipp le Coutre, et al.. (2016). Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis: a snapshot of 1144 patients in the JUMP trial. Haematologica. 101(9). 1065–1073. 119 indexed citations
5.
Efficace, Fabio, Gianantonio Rosti, Massimo Breccia, et al.. (2015). The impact of comorbidity on health-related quality of life in elderly patients with chronic myeloid leukemia. Annals of Hematology. 95(2). 211–219. 15 indexed citations
6.
Palandri, Francesca, Roberto Latagliata, Nicola Polverelli, et al.. (2015). Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosis. Leukemia. 29(6). 1344–1349. 46 indexed citations
7.
Pagano, Livio, Luisa Verga, Alessandro Busca, et al.. (2014). Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey. Journal of Antimicrobial Chemotherapy. 69(11). 3142–3147. 16 indexed citations
8.
Rossi, Andrea, Massimo Breccia, Elisabetta Abruzzese, et al.. (2012). Outcome of 82 chronic myeloid leukemia patients treated with nilotinib or dasatinib after failure of two prior tyrosine kinase inhibitors. Haematologica. 98(3). 399–403. 39 indexed citations
10.
Pagano, Livio, Morena Caira, Massimo Offidani, et al.. (2010). Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study). Journal of Antimicrobial Chemotherapy. 65(9). 2013–2018. 14 indexed citations
12.
Piccoli, Giorgina Barbara, Manuel Burdese, Elisabetta Mezza, et al.. (2002). Teaching Technology with Technology: Computer Assisted Lessons in the Medical School - The First Italian Experience in Nephrology and Dialysis. The International Journal of Artificial Organs. 25(9). 860–866. 4 indexed citations
13.
Menichetti, F., P. Martino, Giampaolo Bucaneve, et al.. (2001). A Multicenter, Double‐Blind, Placebo‐Controlled Trial Comparing Piperacillin‐Tazobactam with and without Amikacin as Empiric Therapy for Febrile Neutropenia. Clinical Infectious Diseases. 33(8). 1295–1301. 111 indexed citations
14.
Pagano, Livio, Alessandro Pulsoni, Luca Mele, et al.. (2001). Acute myeloid leukemia in patients previously diagnosed with breast cancer: Experience of the GIMEMA group. Annals of Oncology. 12(2). 203–208. 14 indexed citations
15.
Pulsoni, Alessandro, Livio Pagano, Maria Elena Tosti, et al.. (2000). Retrospective survival analysis of elderly patients with acute myeloid leukemia (AML) treated with aggressive or non aggressive therapy. 2 indexed citations
16.
Pagano, Livio, Alessandro Pulsoni, Maria Elena Tosti, et al.. (1999). Acute lymphoblastic leukaemia occurring as second malignancy: report of the GIMEMA Archive of Adult Acute Leukaemia. British Journal of Haematology. 106(4). 1037–1040. 57 indexed citations
17.
Iacopino, Pasquale, et al.. (1986). Acute leukemia with lymphoid/myeloid cell populations (hybrid leukemia). Case reports.. PubMed. 19(2). 117–20. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026